Angiotensin Converting Enzyme (ACE)

Elevated serum ACE often indicates granulomatous inflammation—most commonly sarcoidosis—and may reflect active disease and organ involvement (lungs, lymph nodes, eyes, skin). It can also be raised in tuberculosis, certain fungal infections, silicosis, some liver or endocrine disorders, and malignancies. High ACE is not diagnostic alone; further evaluation (imaging, specialist assessment, sometimes biopsy) is needed to determine cause and guide treatment.

The angiotensin‑converting enzyme (ACE) converts inactive angiotensin I into angiotensin II, a potent vasoconstrictor that raises blood pressure and stimulates aldosterone release, promoting sodium and water retention. ACE also breaks down bradykinin, a vasodilator. By regulating angiotensin II and bradykinin levels, ACE plays a central role in vascular tone, fluid balance, and blood pressure control, especially in lung endothelium.

ACE inhibitors are blood-pressure medications typically ending in “-pril.” Common examples include lisinopril, ramipril, enalapril, perindopril, captopril, benazepril, fosinopril, quinapril, trandolapril and moexipril. They reduce angiotensin II production to lower blood pressure and decrease heart strain; used for hypertension, heart failure and post‑MI management under medical supervision. Common side effects include cough, dizziness, elevated potassium and rare angioedema.

An ACE level above the laboratory’s upper limit of normal is considered elevated and can support a diagnosis of sarcoidosis. Many labs use a cutoff around 52 U/L (values often range ~8–53 U/L), but reference ranges vary by assay and age. Elevated ACE is neither sensitive nor specific and should be interpreted alongside clinical, radiologic, and histologic findings.

ACE inhibitors primarily lower blood pressure by blocking angiotensin II production and reducing vascular resistance. They do not usually produce a significant direct change in resting heart rate, though they can lessen reflex tachycardia and, over time, reduce sympathetic drive in heart failure. Heart-rate effects are generally indirect; bradycardia is uncommon unless combined with other rate-lowering drugs.

A high ACE score is linked with greater risk of mental health problems (depression, anxiety, PTSD), substance misuse and suicide, and increased likelihood of risky behaviors (smoking, early sexual activity). It also raises long-term risk of chronic physical conditions—heart disease, stroke, diabetes, respiratory disease, obesity—along with impaired immune function, poorer social/educational outcomes, and reduced life expectancy.